[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.3857/roj.2016.01970

Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines

Rim, Chai Hong (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine)
Seong, Jinsil (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine)

Publication Information

Radiation Oncology Journal / v.34, no.3, 2016 , pp. 160-167 More about this Journal

Abstract

In oncologic practice, treatment guidelines provide appropriate treatment strategies based on evidence. Currently, many guidelines are used, including those of the European Association for the Study of the Liver and European Organization for Research and Treatment of Cancer (EASL-EORTC), National Comprehensive Cancer Network (NCCN), Asia-Pacific Primary Liver Cancer Expert (APPLE), and Korean Liver Cancer Study Group and National Cancer Centre (KLCSG-NCC). Although radiotherapy is commonly used in clinical practice, some guidelines do not accept it as a standard treatment modality. In this review, we will investigate the clinical practice guidelines currently used, and discuss the application of radiotherapy.

Keywords

Radiotherapy; Hepatocellular carcinoma; Practice guideline;

Citations & Related Records

Times Cited By KSCI : 3 (Citation Analysis)

Reference
Cited By KSCI

1	Yoon SM, Kim JH, Choi EK, et al. Radioresponse of hepatocellular carcinoma-treatment of lymph node metastasis. Cancer Res Treat 2004;36:79-84. DOI
2	Huang JF, Wang LY, Lin ZY, et al. Incidence and clinical outcome of icteric type hepatocellular carcinoma. J Gastroenterol Hepatol 2002;17:190-5. DOI
3	Im JH, Yoon SM, Park HC, et al. Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area. Liver Int 2016 Jun 18 [Epub]. http://dx.doi.org/10.1111/liv.13191.
4	Qi WX, Fu S, Zhang Q, Guo XM. Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: a systematic review and meta-analysis. Radiother Oncol 2015;114:289-95. DOI
5	National Cancer Institute. Levels of evidence for adult and pediatric cancer treatment studies (PDQ) [Internet]. Bethesda, MD: National Cancer Institute; c2015 [cited 2016 Aug 17]. Available from: https://www.cancer.gov/publications/pdq/levels-evidence/treatment.
6	Andrews J, Guyatt G, Oxman AD, et al. GRADE guidelines: 14. going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 2013;66:719-25. DOI
7	Guyatt GH, Oxman AD, Kunz R, et al. Going from evidence to recommendations. BMJ 2008;336:1049-51. DOI
8	National Comprehensive Cancer Network. NCCN categories of evidence and consensus. [Internet]. Fort Washington, PA: National Comprehensive Cancer Network; c2016 [cited 2016 Aug 17]. Available from: https://www.nccn.org/professionals/physician_gls/categories_of_consensus.asp.
9	Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329-38. DOI
10	Marrero JA, Fontana RJ, Barrat A, et al. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 2005;41:707-16. DOI
11	Cillo U, Bassanello M, Vitale A, et al. The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? J Hepatol 2004;40:124-31.
12	Gomaa AI, Hashim MS, Waked I. Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt. PLoS One 2014;9:e90929. DOI
13	Hsu C, Chen BB, Chen CH, et al. Consensus development from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014). Liver Cancer 2015;4:96-105. DOI
14	Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-2. DOI
15	European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908-43. DOI
16	Huo TI, Huang YH, Lee SD, Wu JC. Is there an ideal prognostic model for hepatocellular carcinoma? Gut 2005;54:1348.
17	Dawson LA, McGinn CJ, Normolle D, et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 2000;18:2210-8. DOI
18	Seong J, Park HC, Han KH, Chon CY. Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 2003;55:329-36. DOI
19	Han KH, Seong J, Kim JK, Ahn SH, Lee DY, Chon CY. Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis. Cancer 2008;113:995-1003. DOI
20	Chen SW, Lin LC, Kuo YC, Liang JA, Kuo CC, Chiou JF. Phase 2 study of combined sorafenib and radiation therapy in patients with advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2014;88:1041-7. DOI
21	Yoon SM, Lim YS, Won HJ, et al. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes. Int J Radiat Oncol Biol Phys 2012;82:2004-11. DOI
22	Kim SW, Oh D, Park HC, et al. Transcatheter arterial chemoembolization and radiation therapy for treatment-naive patients with locally advanced hepatocellular carcinoma. Radiat Oncol J 2014;32:14-22. DOI
23	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108. DOI
24	National Comprehensive Cancer Network [Internet]. Fort Washington, PA: National Comprehensive Cancer Network; c2016 [cited 2016 Aug 17]. Available from: https://www.nccn.org.
25	National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology, hepatobiliary cancers 2015. Fort Washington, PA: National Comprehensive Cancer Network; c2016.
26	National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology, hepatobiliary cancers 2016. 2 [Internet]. Fort Washington, PA: National Comprehensive Cancer Network; c2016 [cited 2016 Aug 17]. Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
27	Head HW, Dodd GD 3rd, Dalrymple NC, et al. Percutaneous radiofrequency ablation of hepatic tumors against the diaphragm: frequency of diaphragmatic injury. Radiology 2007;243:877-84. DOI
28	Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005;234:961-7. DOI
29	Llovet JM, Vilana R, Bru C, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001;33:1124-9. DOI
30	Pillai K, Akhter J, Chua TC, et al. Heat sink effect on tumor ablation characteristics as observed in monopolar radiofrequency, bipolar radiofrequency, and microwave, using ex vivo calf liver model. Medicine (Baltimore) 2015;94:e580. DOI
31	Sanuki N, Takeda A, Kunieda E. Role of stereotactic body radiation therapy for hepatocellular carcinoma. World J Gastroenterol 2014;20:3100-11. DOI
32	Park HC, Yu JI, Cheng JC, et al. Consensus for radiotherapy in hepatocellular carcinoma from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): current practice and future clinical trials. Liver Cancer 2016;5:162-74. DOI
33	Kim TH, Kim DY, Park JW, et al. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with threedimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2007;67:225-31. DOI
34	Cheng JC, Wu JK, Huang CM, et al. Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease. Int J Radiat Oncol Biol Phys 2003;56:229-34. DOI
35	Bush DA, Hillebrand DJ, Slater JM, Slater JD. High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial. Gastroenterology 2004;127(5 Suppl 1):S189-93. DOI
36	Hamacher HW, Kufer KH. Inverse radiation therapy planning: a multiple objective optimization approach. Discrete Appl Math 2002;118:145-61. DOI
37	ClinicalTrials.gov [Internet]. Bethesda, MD: ClinicalTrials. gov; c2016 [cited 2016 Aug 17]. Available from: https://clinicaltrials.gov/.
38	DeLaney TF. Proton therapy in the clinic. Front Radiat Ther Oncol 2011;43:465-85.
39	Nakayama H, Sugahara S, Tokita M, et al. Proton beam therapy for hepatocellular carcinoma: the University of Tsukuba experience. Cancer 2009;115:5499-506. DOI
40	Hata M, Tokuuye K, Sugahara S, et al. Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis. Strahlenther Onkol 2006;182:713-20. DOI
41	Korean Liver Cancer Study Group (KLCSG); National Cancer Center, Korea (NCC). 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma. Korean J Radiol 2015;16:465-522. DOI
42	Union for International Cancer Control (UICC). UICC staging system [Internet]. Geneva: Union for International Cancer Control (UICC); c2016 [cited 2016 Aug 17]. Available from: http://www.uicc.org.
43	Hawkins MA, Dawson LA. Radiation therapy for hepatocellular carcinoma: from palliation to cure. Cancer 2006;106:1653-63. DOI
44	Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A, Gaspar LE. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 2005;62:1371-8. DOI
45	Jiang W, Zeng ZC, Zhang JY, Fan J, Zeng MS, Zhou J. Palliative radiation therapy for pulmonary metastases from hepatocellular carcinoma. Clin Exp Metastasis 2012;29:197-205. DOI
46	Pan CC, Kavanagh BD, Dawson LA, et al. Radiationassociated liver injury. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S94-100. DOI
47	Choi HJ, Cho BC, Sohn JH, et al. Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC. J Neurooncol 2009;91:307-13. DOI
48	He J, Zeng ZC, Tang ZY, et al. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy. Cancer 2009;115:2710-20. DOI
49	Meng MB, Cui YL, Lu Y, et al. Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysis. Radiother Oncol 2009;92:184-94. DOI

6	(2016) Langenbeck's archives of surgery Bridging to liver transplantation in HCC patients / 402 (6) , 863
None	(2016) F1000Research Development of a deep neural network derived from contours defined by consensus-based guidelines for automatic target segmentation in hepatocellular carcinoma radiotherapy: A study protocol / 6 (None) , 1929
35	(2017) Oncotarget Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results / 8 (35) , 59965
55	(2017) Oncotarget Prognostic group stratification and nomogram for predicting overall survival in patients who received radiotherapy for abdominal lymph node metastasis from hepatocellular carcinoma: a multi-institutio / 8 (55) , 94450
16	(2016) Future microbiology γ-irradiation from radiotherapy improves the virulence potential of <I>Candida tropicalis</I> / 12 (16) , 1467
3	(2016) Oncotarget Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma / 9 (3) , 4034
None	(2016) OncoTargets and therapy Leaflet manual of external beam radiation therapy for hepatocellular carcinoma: a review of the indications, evidences, and clinical trials / 11 (None) , 2865
None	(2016) Cancer management and research The role of external beam radiotherapy for hepatocellular carcinoma patients with lymph node metastasis: a meta-analysis of observational studies / 10 (None) , 3305
2	(2016) Cell death & disease MicroRNA-146a-5p attenuates irradiation-induced and LPS-induced hepatic stellate cell activation and hepatocyte apoptosis through inhibition of TLR4 pathway / 9 (2) , 22
2	(2018) Hepatic oncology Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review / 5 (2) , HEP07
2	(2016) Cancer research and treatment : official journal of Korean Cancer Association The Clinical Utilization of Radiation Therapy in Korea between 2011 and 2015 / 50 (2) , 345
3	(2016) Annals of hepato-biliary-pancreatic surgery Long-term complete response after transcatheter arterial chemoembolization and stereotactic body radiation therapy in a patient with hepatocellular carcinoma at the caudate lobe / 22 (3) , 274
1	(2018) Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology External beam radiation therapy to hepatocellular carcinoma involving inferior vena cava and/or right atrium: A meta-analysis and systemic review / 129 (1) , 123
11	(2018) Strahlentherapie und Onkologie Compensatory hypertrophy of the liver after external beam radiotherapy for primary liver cancer / 194 (11) , 1017
None	(2016) Scientific reports Evaluation of Hepatic Toxicity after Repeated Stereotactic Body Radiation Therapy for Recurrent Hepatocellular Carcinoma using Deformable Image Registration / 8 (None) , 16224
None	(2016) BMC cancer Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma / 18 (None) , 416
None	(2016) BMC cancer Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma / 18 (None) , 1040
None	(2016) Cancer management and research Role of local treatment including radiotherapy in Barcelona Clinic of Liver Cancer stage C patients: a nationwide cohort analysis in South Korea / 11 (None) , 1373
None	(2016) Frontiers in oncology Safety and Efficacy of Transcatheter Arterial Chemoembolization Plus Radiotherapy Combined With Sorafenib in Hepatocellular Carcinoma Showing Macrovascular Invasion / 9 (None) , 1065
2	(2019) Cancers Does Risk-Adapted Proton Beam Therapy Have a Role as a Complementary or Alternative Therapeutic Option for Hepatocellular Carcinoma? / 11 (2) , 230
2	(2016) Australasian physical & engineering sciences in medicine Dose verification for liver target volumes undergoing respiratory motion / 42 (2) , 619
8	(2016) International journal of radiation biology Radioprotective effects of mistletoe extract in zebrafish embryos in vivo / 95 (8) , 1150
2	(2019) Journal of liver cancer Long-term Disease-free Survival after Trimodality Treatment of Recurrent Hepatocellular Carcinoma Involving the Inferior Vena Cava and Right Atrium / 19 (2) , 149
4	(2016) Cancer research and treatment : official journal of Korean Cancer Association Treatment Outcome after Fractionated Conformal Radiotherapy for Hepatocellular Carcinoma in Patients with Child-Pugh Classification B in Korea (KROG 16-05) / 51 (4) , 1589
5	(2016) International journal of radiation oncology, biology, physics Safety and Efficacy of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma After Segmental Transarterial Radioembolization / 105 (5) , 968
12	(2016) Acta oncologica Stereotactic body radiation therapy for early-stage hepatocellular carcinoma - a systematic review on outcome / 58 (12) , 1706
None	(2020) Technology in cancer research & treatment Helical IMRT-Based Stereotactic Body Radiation Therapy Using an Abdominal Compression Technique and Modified Fractionation Regimen for Small Hepatocellular Carcinoma / 19 (None) , 1533033820937002
None	(2016) Journal of hepatocellular carcinoma Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion / 7 (None) , 403
4	(2020) World journal of gastroenterology : WJG Indications of external radiotherapy for hepatocellular carcinoma from updated clinical guidelines: Diverse global viewpoints / 26 (4) , 393
1	(2016) International journal of radiation oncology, biology, physics Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib for Advanced Hepatocellular Carcinoma: A Prospective Phase 2 Trial / 107 (1) , 106
2	(2016) Journal of liver cancer Huge Hepatocellular Carcinoma Exhibiting a Complete Response after Stereotactic Body Radiation Therapy / 20 (2) , 167
None	(2016) Frontiers in oncology lncRNA MIR22HG-Derived miR-22-5p Enhances the Radiosensitivity of Hepatocellular Carcinoma by Increasing Histone Acetylation Through the Inhibition of HDAC2 Activity / 11 (None) , 572585
8	(2016) World journal of gastrointestinal surgery Treatment for hepatocellular carcinoma with tumor thrombosis in the hepatic vein or inferior vena cava: A comprehensive review / 13 (8) , 796
1	(2022) Transplantation De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management-Guidelines From the ILTS-SETH Consensus Conference / 106 (1) , e30
1	(2016) Archiv der Pharmazie Green synthesis of novel antifungal 1,2,4‐triazoles effective against γ‐irradiated <I>Candida parapsilosis</I> / 355 (1) , 2100287